Background: Whether endovascular therapy (EVT) added on best medical management
(BMM), as compared to BMM alone, is beneficial in acute ischemic stroke with isolated …

Background and Purpose: Acute ischemic stroke and large vessel occlusion can be
concurrent with the coronavirus disease 2019 (COVID-19) infection. Outcomes after …

BACKGROUND: The mechanisms and outcomes in coronavirus disease (COVID-19)–
associated stroke are unique from those of non–COVID-19 stroke. OBJECTIVE: To describe …

Purpose Cangrelor is an intravenous P2Y12 receptor inhibitor with a rapid onset/offset of
action and a short half-life (3–6 min). The objective was to present a preliminary experience …

Background The coronavirus disease 2019 (COVID-19) pandemic is an ongoing public
health emergency. While most cases end in asymptomatic or minor illness, there is growing …

Introduction: First pass effect (FPE), achievement of complete recanalization (mTICI 2c/3)
with a single pass, is a significant predictor of favorable outcomes for endovascular …

Purpose Thromboembolic events represent the most common procedure-related
complication associated with neurointerventions. Cangrelor is a potent, intravenous (IV) …

Background Distal vessel occlusions represent about 25-40% of acute ischemic stroke (AIS),
either as primary occlusion or secondary occlusion complicating mechanical thrombectomy …

Background Endovascular treatment (EVT) for basilar artery occlusions (BAO) is associated
with a higher rate of futile recanalization compared with anterior circulation procedures. We …

Background For acute proximal intracranial artery occlusions, contact aspiration may be
more effective than stent‐retriever for first‐line reperfusion therapy. Due to the lack of data …